These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11192367

  • 1. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
    Nakano A, Cohen MV, Critz S, Downey JM.
    Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
    [Abstract] [Full Text] [Related]

  • 2. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM.
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C, Liu GS, Cohen MV, Downey JM.
    J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
    [Abstract] [Full Text] [Related]

  • 5. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD.
    Circ Res; 2000 Feb 04; 86(2):144-51. PubMed ID: 10666409
    [Abstract] [Full Text] [Related]

  • 6. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart.
    Gysembergh A, Simkhovich BZ, Kloner RA, Przyklenk K.
    J Mol Cell Cardiol; 2001 Apr 04; 33(4):681-90. PubMed ID: 11273721
    [Abstract] [Full Text] [Related]

  • 7. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
    Lochner A, Genade S, Hattingh S, Marais E, Huisamen B, Moolman JA.
    Cardiovasc Drugs Ther; 2003 May 04; 17(3):217-30. PubMed ID: 14574080
    [Abstract] [Full Text] [Related]

  • 8. SAPKs regulation of ischemic preconditioning.
    Sato M, Cordis GA, Maulik N, Das DK.
    Am J Physiol Heart Circ Physiol; 2000 Sep 04; 279(3):H901-7. PubMed ID: 10993748
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
    Barancik M, Htun P, Strohm C, Kilian S, Schaper W.
    J Cardiovasc Pharmacol; 2000 Mar 04; 35(3):474-83. PubMed ID: 10710135
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
    Schneider S, Chen W, Hou J, Steenbergen C, Murphy E.
    Am J Physiol Heart Circ Physiol; 2001 Feb 04; 280(2):H499-508. PubMed ID: 11158945
    [Abstract] [Full Text] [Related]

  • 11. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart.
    Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD.
    Cardiovasc Res; 2002 Aug 15; 55(3):681-9. PubMed ID: 12160965
    [Abstract] [Full Text] [Related]

  • 12. SB 203580, a mitogen-activated protein kinase inhibitor, abolishes resistance to myocardial infarction induced by heat stress.
    Joyeux M, Boumendjel A, Carroll R, Ribuot C, Godin-Ribuot D, Yellon DM.
    Cardiovasc Drugs Ther; 2000 Jun 15; 14(3):337-43. PubMed ID: 10935156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E, Genade S, Strijdom H, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Dec 15; 33(12):2157-77. PubMed ID: 11735262
    [Abstract] [Full Text] [Related]

  • 17. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.
    Wang P, Downey JM, Cohen MV.
    Basic Res Cardiol; 1996 Dec 15; 91(6):458-67. PubMed ID: 8996631
    [Abstract] [Full Text] [Related]

  • 18. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
    Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M.
    Circ Res; 2001 Feb 02; 88(2):175-80. PubMed ID: 11157669
    [Abstract] [Full Text] [Related]

  • 19. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning.
    Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV.
    J Mol Cell Cardiol; 2000 Jul 02; 32(7):1159-67. PubMed ID: 10860760
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
    Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL.
    Circulation; 1999 Apr 06; 99(13):1685-91. PubMed ID: 10190877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.